C raniopharyngiomas are benign tumors derived from the squamous epithelium of the Rathke pouch or the craniopharyngeal duct when persisting after embryogenesis. They account for approximately 2%-3% of all brain tumors, and for 6%-10% of pediatric intracranial tumors. 21, 36 Despite their benign histopathological features, craniopharyngiomas can infiltrate the surrounding structures, making total resection difficult without causing permanent neurological deficits. More than 70% of all primary craniopharyngiomas show infrasellar and suprasellar growth.
by severe loss of visual acuity and complete amaurosis of the left eye. Histopathological investigation revealed the tumor to be an adamantinomatous craniopharyngioma. In 2002 the patient presented to our neurosurgical department at the age of 68 years. She had experienced chronic headaches, and an MRI study showed local recurrence of a craniopharyngioma that was 1.5 × 1.2 cm. Stereotactic cyst aspiration and implantation of a Rickham catheter were performed. The patient received stereotactic fractionated radiotherapy, with a total dose of 52.2 Gy. Subsequently, significant shrinkage of the tumor was seen, with a stable ophthalmological status.
Yearly MRI follow-up studies were performed that showed no progression of the residual lesion.
In 2007, at the age of 72 years, the patient's MRI study revealed a 6.6 × 4.4-mm contrast-enhancing lesion in the right supraorbital region penetrating the external table of the frontal bone just lateral to the osteosynthesis plates placed during the first surgery (prints only [nondigital] MRI). Because the patient was symptom free, watchful waiting was performed with control MRI studies.
In 2011 the lesion had progressed to a size of 19 × 18 mm, causing an indolent swelling above the right eye. The MRI study showed 2 cysts facing the subcutaneous soft tissue and a solid, hyperdense, partly calcified portion facing the dura mater (see Fig. 1B and C). No intradural growth was seen. Differential diagnoses were granuloma and chronic infection. Additional CT scans revealed osteolytic destruction of both the external and internal tables of the frontal bone (Fig. 1E) . The patient was concerned about cosmetic consequences of the progressive lesion.
One month later, at the age of 77 years, the patient underwent resection of the supraorbital tumor via a lateral eyebrow approach. A small lipomatous portion was removed. The 2 cysts were punctured and the fluid aspirated. One cyst contained motor-oil-like fluid, whereas the other one contained thick yellow fluid. Microbiological assessment showed no signs of bacterial or fungal growth. The rest of the tumor was totally removed, guided by neuronavigation. Total penetration of the frontal bone without involvement of the epidural space or the dura itself was seen. Bone cement was used to fill the defect. Histopathological assessment revealed the lesion to be an adamantinomatous craniopharyngioma with typical horn beads (Fig. 2 left) and a Ki 67 proliferation index of 5% (Fig. 2 right) . The postoperative course was uneventful. The patient was informed about the ectopic recurrence of craniopharyngioma, and yearly MRI examinations were planned.
To reiterate, this patient had a rare case of ectopic recurrence of adamantinomatous craniopharyngioma of the right supraorbital frontal bone that was radiographically detected 12 years after removal of the original lesion and was resected 4 years later. The tumor was located just lateral to the osteosynthesis plates implanted at the site of the craniotomy and did not invade the dura mater or the brain.
Discussion
Whereas local recurrence is common after GTR of craniopharyngiomas, ectopic recurrence is a very rare phenomenon. Two different mechanisms for ectopic recurrence have been described. The first mechanism is seed metastasis along the surgical tract; recurrence is attributed to iatrogenic contamination of healthy tissue with tumor cells in the process of removing parts of the tumor during surgery. However, which surgical techniques are associated with a higher risk of seed implantation is currently unknown. The second mechanism involves spreading of craniopharyngioma cells via CSF, because the basal cisterns and the Liliequist membrane are frequently opened during surgery. 8, 40 Another rare entity is primary ectopic craniopharyngioma, which has been described in the posterior fossa and the epidural space, 2 and is attributable to misspread cells during embryogenesis. Primary infrasellar craniopharyngioma can be found alongside the anatomical path of the craniopharyngeal duct (sphenoid sinus, ethmoid bone, nasopharyngeal space).
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To our knowledge true metastasis of craniopharyngioma (that is, sellar craniopharyngioma and synchronistic ectopic lesions) has not yet been described. All cases of ectopic recurrence have appeared after surgery or manipulation of the primary tumor. Obviously, single craniopharyngioma cells have the ability to create new lesions when seeded in healthy tissue; however, there is no evidence that they are capable of separating themselves from the tumor to metastasize via the vascular or CSF systems. 19 However, malignant transformation to squamous cell carcinoma associated with radiation therapy has been described in single cases. 16 The Ki 67 proliferation indexes reported in the literature were higher in recurrent tumors compared with the primary lesion, and as high as 8%. 32, 40, 44 However, Jeong et al. 20 reported a stable 3.0% Ki 67 proliferation index for both primary and secondary craniopharyngioma. Therefore, whether recurrent craniopharyngiomas have a higher cell proliferation is not yet fully proven, because the literature does not give a definitive answer and bigger studies are impractical considering the very limited number of cases. Vascular endothelial growth factor and its receptor are reported to be significantly more highly expressed for ectopic recurrences than for the primary lesion. Tumor cells showed positive immunohistochemical staining of up to 33%, whereas in the primary tumor neither vascular endothelial growth factor nor its receptor could be detected on tumor cells. 9 The role of angiogenesis in ectopic recurrence of craniopharyngioma has yet to be established.
Our manuscript presents a case of ectopic craniopharyngioma of the frontal bone in the right supraorbital area that was first diagnosed 12 years after transcranial surgery. Because the tumor was located right next to the osteosynthesis plate implanted at the site of the bifrontal craniotomy, it is highly likely to be a case of ectopic recurrence along the surgical tract.
As the CT scans clearly indicate, the tumor grew from the outside first, penetrating the external table (2009; Fig. 1D ) and later the internal table (2011; Fig. 1E ) of the frontal bone. Because the tumor was located along the surgical tract, we assume that craniopharyngioma cells contaminated the external table of the frontal bone during the initial surgery. Either parts of excised tumor tissue had come in contact with the frontal bone during resection, or single cells had disintegrated from removed tumor parts and contaminated the unprotected skull.
Considering the location of the lesion right next to the osteosynthesis plate, contamination of the implanted materials is speculated to be another way to spread craniopharyngioma cells.
In our retrospective assessment of all the MRI studies performed since the stereotactic Rickham catheter placement for cyst aspiration, a small 2-mm contrastenhancing lesion can be found at the site of the tumor as early as 2002 (Fig. 1A) . This small solid lesion is present in every subsequent MRI study and develops 2 cysts as it grows in size and starts penetrating the frontal bone. The lesion was first diagnosed 5 years later by neuroradiologists when it had reached a size of 6.6 × 4.4 mm (using printed MRI studies only; digital imaging was not available).
Differential diagnoses ranged from chronic infection to foreign-body granuloma, which was our working diagnosis because the lesion was located right next to the osteosynthesis plate.
After the histopathological diagnosis of adamantinomatous craniopharyngioma, we performed a thorough literature review and found 50 published cases of ectopic recurrence. However, to the best of our knowledge our case is the first one presenting with extracranial ectopic recurrent craniopharyngioma. Table 1 displays all published cases of ectopic recurrence of craniopharyngioma (including this case report) found during a thorough literature review. We performed basic statistical analysis (Table 2 ) regarding time till ec- topic recurrence and other parameters. This analysis is limited by the small number and heterogeneous causes of cases published, and therefore should be taken as a summary rather than as evidence. Ectopic recurrence may occur in a very wide time range after resection (1 month-26 years), with a median of 4 years ( Table 1) . It seems that male and female patients are equally affected by ectopic recurrence (43% female, 57% male; Table 2 ), although craniopharyngiomas in general occur more often in male patients. 21 Pediatric and adult patients were equally affected (27 vs 24 cases). Pediatric patients were predominantly male (62%) and boys had a lower median age than girls at the time of first surgery (6 years vs 7 years).
Rates of GTR and STR of the primary tumor were roughly the same for adult and pediatric patients (GTR 67% vs 78%; STR 26% vs 22%). Radiation therapy was most often performed after STR (60%).
As far as the location of ectopic recurrence is concerned, the frontal lobe is the most common site (23 cases). Epidural and sylvian fissure ectopic recurrence was always associated with implantation of tumor cells along the surgical tract. Spreading via CSF and seed implantation along the surgical tract occur almost equally (CSF 44%, surgical tract 56%). Location of ectopic recurrent craniopharyngioma in the posterior fossa, the spinal cord, the cerebellopontine angle and the prepontine cisterns was strictly associated with CSF contamination and spreading of tumor cells ( Table 2) .
The mean time until ectopic recurrence was shorter when occurring along the surgical tract compared with CSF spreading (mean time 5.8 years vs 9.7 years, Table 2 ). Ectopic recurrence occurs significantly faster after STR compared with GTR (p = 0.085; 6.6 years vs 10.9 years). Pediatric and adult patients had similar mean times until ectopic recurrence (7.6 years vs 6.4 years).
Because the number of published cases of ectopic recurrent craniopharyngioma is very limited, reliable statistics cannot be provided. However, our collection of data shows some general trends, as follows. First, adults and pediatric patients are equally affected by ectopic recurrence. Second, ectopic recurrence occurs significantly earlier after STR. Third, all patients with ectopic recurrence underwent transcranial surgery; to the best of our knowledge none of the published cases includes patients who had transsphenoidal resection. After initial surgery, patients should be thoroughly instructed to undergo regular follow-up CT or MRI studies to diagnose local or ectopic recurrence as early as possible.
Conclusions
Ectopic recurrence of craniopharyngiomas is a rare phenomenon. Spreading via CSF and alongside the surgical tract are phenomena that can be attributed to contamination of healthy tissue. From the current point of view, the risk of ectopic recurrence can be minimized by following some principles. Gross-total resection should be the ideal goal of any craniopharyngioma surgery. However, as our case report shows, the patient suffered severe complications after initial surgery at another neurosurgical department. Partial resection followed by radiotherapy can be a valid surgical goal when persisting neurological deficits are to be expected. Transsphenoidal resection seems to decrease the risk of ectopic recurrence. Unintentional opening of cysts should be avoided, and controlled aspiration without spilling fluid is recommended. Our case demonstrates that not only the intracranial surgical tract can be affected by ectopic recurrence, but also the skull bones. Meticulous handling of the tumor or removed parts is advised.
Although only 51 cases of ectopic recurrent craniopharyngioma (including ours) have been described so far, it should always be considered in patients with a second intracranial tumor after craniopharyngioma resection.
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